Literature DB >> 16099056

Clonal expansion of IgA-positive plasma cells and axon-reactive antibodies in MS lesions.

Yiping Zhang1, Reng-Rong Da, Lutz G Hilgenberg, Wallace W Tourtellotte, Raymond A Sobel, Martin A Smith, Michael Olek, Rashed Nagra, Gupta Sudhir, Stanley van den Noort, Yufen Qin.   

Abstract

Immunoglobulin A (IgA), the predominant immunoglobulin class in mucosal secretions, has been found in the cerebrospinal fluid of patients with multiple sclerosis (MS). In this study we examined the infiltration of clonally expanded IgA plasma cells in lesions of MS brains. Sequences of complementarity-determining region 3 of IgA variable heavy chain (V(H)) genes demonstrated the clonal expansion of IgA-bearing plasma cells in MS lesions. Somatic mutations and ongoing intra-clonal mutations occurred in their V(H) genes. Immunohistochemical study demonstrated infiltration of dimer and polymer IgA1- and A2-positive plasma cells in perivascular spaces, in the parenchyma of MS lesions, and in the adjacent white matter. Double immunofluorescence staining showed binding of IgA antibody on axons and walls of microvessels in the areas of chronic active and inactive demyelination. Bielshowsky's silver impregnation revealed axonal damage in these areas. These findings suggest that IgA in the CNS are localized on axons in lesions and may contribute to axonal damage in MS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16099056     DOI: 10.1016/j.jneuroim.2005.05.006

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  16 in total

1.  Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progression.

Authors:  Haipeng Shao; Liqiang Xi; Mark Raffeld; Stefania Pittaluga; Kieron Dunleavy; Wyndham H Wilson; Nelson Spector; Cristiane Milito; Jose Carlos Morais; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2010-10       Impact factor: 6.394

Review 2.  The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment.

Authors:  Andrew P Robinson; Christopher T Harp; Avertano Noronha; Stephen D Miller
Journal:  Handb Clin Neurol       Date:  2014

3.  Complex gene-gene interactions in multiple sclerosis: a multifactorial approach reveals associations with inflammatory genes.

Authors:  Alison A Motsinger; David Brassat; Stacy J Caillier; Henry A Erlich; Karen Walker; Lori L Steiner; Lisa F Barcellos; Margaret A Pericak-Vance; Silke Schmidt; Simon Gregory; Stephen L Hauser; Jonathan L Haines; Jorge R Oksenberg; Marylyn D Ritchie
Journal:  Neurogenetics       Date:  2006-09-22       Impact factor: 2.660

4.  Peptide reactivity between multiple sclerosis (MS) CSF IgG and recombinant antibodies generated from clonally expanded plasma cells in MS CSF.

Authors:  Xiaoli Yu; Don Gilden; Laura Schambers; Olga Barmina; Mark Burgoon; Jeffrey Bennett; Greg Owens
Journal:  J Neuroimmunol       Date:  2010-12-21       Impact factor: 3.478

Review 5.  A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  Avijit Ray; Monica K Mann; Sreemanti Basu; Bonnie N Dittel
Journal:  J Neuroimmunol       Date:  2010-12-10       Impact factor: 3.478

6.  B-lymphocyte-mediated delayed cognitive impairment following stroke.

Authors:  Kristian P Doyle; Lisa N Quach; Montse Solé; Robert C Axtell; Thuy-Vi V Nguyen; Gilberto J Soler-Llavina; Sandra Jurado; Jullet Han; Lawrence Steinman; Frank M Longo; Julie A Schneider; Robert C Malenka; Marion S Buckwalter
Journal:  J Neurosci       Date:  2015-02-04       Impact factor: 6.167

7.  Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis.

Authors:  Anne-Katrin Pröbstel; Xiaoyuan Zhou; Ryan Baumann; Sven Wischnewski; Michael Kutza; Olga L Rojas; Katrin Sellrie; Antje Bischof; Kicheol Kim; Akshaya Ramesh; Ravi Dandekar; Ariele L Greenfield; Ryan D Schubert; Jordan E Bisanz; Stephanie Vistnes; Khashayar Khaleghi; James Landefeld; Gina Kirkish; Friederike Liesche-Starnecker; Valeria Ramaglia; Sneha Singh; Edwina B Tran; Patrick Barba; Kelsey Zorn; Johanna Oechtering; Karin Forsberg; Lawrence R Shiow; Roland G Henry; Jennifer Graves; Bruce A C Cree; Stephen L Hauser; Jens Kuhle; Jeffrey M Gelfand; Peter M Andersen; Jürgen Schlegel; Peter J Turnbaugh; Peter H Seeberger; Jennifer L Gommerman; Michael R Wilson; Lucas Schirmer; Sergio E Baranzini
Journal:  Sci Immunol       Date:  2020-11-20

Review 8.  B cells and autoantibodies in the pathogenesis of multiple sclerosis and related inflammatory demyelinating diseases.

Authors:  Katherine A McLaughlin; Kai W Wucherpfennig
Journal:  Adv Immunol       Date:  2008       Impact factor: 3.543

9.  Main Role of Antibodies in Demyelination and Axonal Damage in Multiple Sclerosis.

Authors:  Ursula Muñoz; Cristina Sebal; Esther Escudero; Margaret Esiri; John Tzartos; Carolyn Sloan; Mari Cruz Sadaba
Journal:  Cell Mol Neurobiol       Date:  2021-02-24       Impact factor: 5.046

Review 10.  Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review.

Authors:  Tamara Castillo-Trivino; Dejana Braithwaite; Peter Bacchetti; Emmanuelle Waubant
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.